Gene · 1104
Papers1,566
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,566
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparing Antibody Interfaces to Inform Rational Design of New Antibody Formats. | Front Mol Biosci | 2022 | 35155578 | PubTator, text mining | PubMed |
| Selective inhibition of nuclear export: a promising approach in the shifting treatment paradigms for hematological neoplasms. | Leukemia | 2022 | 35091658 | PubTator, text mining | PubMed |
| Function-guided proximity mapping unveils electrophilic-metabolite sensing by proteins not present in their canonical locales. | Proc Natl Acad Sci U S A | 2022 | 35082156 | PubTator, text mining | PubMed |
| HERC3 regulates epithelial-mesenchymal transition by directly ubiquitination degradation EIF5A2 and inhibits metastasis of colorectal cancer. | Cell Death Dis | 2022 | 35064108 | PubTator, text mining | PubMed |
| Novel RCBTB1 variants causing later-onset non-syndromic retinal dystrophy with macular chorioretinal atrophy. | Ophthalmic Genet | 2022 | 35057699 | PubTator, text mining | PubMed |
| ALS2-Related Motor Neuron Diseases: From Symptoms to Molecules. | Biology (Basel) | 2022 | 35053075 | PubTator, text mining | PubMed |
| Immune responses to CCAR1 and other dermatomyositis autoantigens are associated with attenuated cancer emergence. | J Clin Invest | 2022 | 35040440 | PubTator, text mining | PubMed |
| RNF43/ZNRF3 loss predisposes to hepatocellular-carcinoma by impairing liver regeneration and altering the liver lipid metabolic ground-state. | Nat Commun | 2022 | 35039505 | PubTator, text mining | PubMed |
| Gene network profiling in muscle-invasive bladder cancer: A systematic review and meta-analysis. | Urol Oncol | 2022 | 35039218 | PubTator, text mining | PubMed |
| Mapping paths through the nuclear pore complex. | Nat Cell Biol | 2022 | 35013557 | PubTator, text mining | PubMed |
| Structural characterization of human importin alpha 7 in its cargo-free form at 2.5 Å resolution. | Sci Rep | 2022 | 35013395 | PubTator, text mining | PubMed |
| Prevalence of RPGR-Mediated Retinal Dystrophy in an Unselected Cohort of Over 5000 Patients. | Transl Vis Sci Technol | 2022 | 34985506 | PubTator, text mining | PubMed |
| CD147 supports paclitaxel resistance via interacting with RanBP1. | Oncogene | 2022 | 34974521 | PubTator, text mining | PubMed |
| Variant Identification in BARD1, PRDM9, RCC1, and RECQL in Patients with Ovarian Cancer by Targeted Next-generation Sequencing of DNA Pools. | Cancer Prev Res (Phila) | 2022 | 34906988 | PubTator, text mining | PubMed |
| CD47 interactions with exportin-1 limit the targeting of m7G-modified RNAs to extracellular vesicles. | J Cell Commun Signal | 2022 | 34841476 | PubTator, text mining | PubMed |
| NR1D1 regulation by Ran GTPase via miR4472 identifies an essential vulnerability linked to aneuploidy in ovarian cancer. | Oncogene | 2022 | 34743206 | PubTator, text mining | PubMed |
| Risk of tract recurrence with stereotactic biopsy of brain metastases: an 18-year cancer center experience. | J Neurosurg | 2022 | 34507279 | PubTator, text mining | PubMed |
| Understanding vaccination communication between health workers and parents: a Tailoring Immunization Programmes (TIP) qualitative study in Serbia. | Hum Vaccin Immunother | 2022 | 34033519 | PubTator, text mining | PubMed |
| How Protein Methylation Regulates Steroid Receptor Function. | Endocr Rev | 2022 | 33955470 | PubTator, text mining | PubMed |
| Proteolysis-targeting chimeras and their implications in breast cancer. | Explor Target Antitumor Ther | 2021 | 36046115 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1104/papers?page=16